BioElectronics Corporation (OTC: BIEL) released a Chairman's Update on June 30, 2026, highlighting sales growth, cost control, and strategic advancements. Chairman Richard Staelin, PhD, noted that the company achieved a small profit for calendar year 2025 after relocating offices and reducing staff to align with operational needs.
The company has launched targeted advertising campaigns aimed at medical professionals, including surgeons, pain specialists, and chiropractors, to increase awareness of its RecoveryRx device as a non-opioid pain management option. Consumer-focused social media advertising targeting Generation X has also been expanded to promote drug-free solutions for chronic musculoskeletal pain.
BioElectronics is actively seeking a clinical trial partner for RecoveryRx in physician-owned ambulatory surgical centers and orthopedic practices. The goal is to conduct a postoperative study that could support qualification for reimbursement under the federal NO PAIN Act initiative, which the company views as a significant long-term opportunity for broader adoption of non-opioid pain technologies.
Internationally, the company continues arbitration proceedings in Singapore and China against a former distributor for breach of contract, aiming to protect its intellectual property and shareholder interests. Meanwhile, the strategic relationship with Electrome Corporation has advanced, with initial supply conditions met and an initial purchase order received. Manufacturing is underway, and Electrome is planning a commercial launch of BioElectronics' pulsed shortwave therapy products, providing another channel to increase consumer access to FDA-cleared pain therapies.
Staelin emphasized that despite challenges, the company is encouraged by growing interest in non-drug pain management solutions and believes BioElectronics is well-positioned in the electroceutical and non-opioid pain management markets. The company intends to continue advancing initiatives for sustainable growth, including clinical market development, professional outreach, consumer education, and international opportunities.
For more information, visit the company's website at https://www.bielcorp.com/.
